News - Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Clinical Pharmacology

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Clinical Pharmacology

	Antiviral Therapy to Treat Hepatitis C Declining In the United States - (DGNews)
	Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced Colorectal Cancer - (DGNews)
	Administering Epinephrine During Cardiac Arrest Does Not Appear to Improve Long-Term Survival - (DGNews)
	Novel Reflux Inhibitor Shows Promise for Difficult-to-Treat GERD: Presented at GASTRO (UEGW/WCOG) 2009 - (DGDispatch)
	Parent Training Complements Medication for Treating Children With Pervasive Developmental Disorders - (DGNews)

News archive

Recent webcasts/CME - Clinical Pharmacology

	Multiple Sclerosis: Tempering Disabilities and Decline--Fundamentals for Managed Markets
	Evolving Strategies for Chronic Idiopathic Thrombocytepenic Purpura
	Advances in the Treatment of NHL: Updates from the 2009 Pan Pacific Lymphoma Conference
	Fibromyalgia: The Patient Who Hurts Too Much
	Patient-Centered Approaches to the Evaluation and Management of Atrial Fibrillation

Webcasts/CME archive

Recent cases - Clinical Pharmacology

	Ulceration Of The Oral Mucosa Induced By Antidepressant Medication: A Case Report
	Dual Antiplatelet Therapy in Coronary Artery Disease: A Case-Based Approach
	Persistent Orocutaneous and Anal Fistulae Induced by Nicorandil: A Case Report
	Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient with Steroid-Resistant Nephrotic Syndrome
	Recurrent Stupor Associated with Chronic Valproic Acid Therapy and Hyperammonemia

Cases archive

my personal edition > clinical pharmacology > news

E-Mail this DGNews to a colleague

DGNews

Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan

NEW YORK -- December 22, 2008 -- An additional indication of concomitant therapy with biguanides has been approved for pioglitazone hydrochloride (Actos) by the Ministry of Health, Labour, and Welfare in Japan, for the treatment of type 2 diabetes.

The approval is based on a randomised, double-blind, comparative study, in which the clinical usefulness of biguanides monotherapy was compared with that of biguanides plus pioglitazone hydrochloride.

Patients receiving biguanides plus pioglitazone hydrochloride showed a statistically significant difference in improving HbA1C without increasing the risk of hypoglycaemia.

Management of type 2 diabetes should also include nutritional counselling, weight reduction as needed, and exercise.

SOURCE: Takeda Pharmaceutical Company Limited

E-Mail this DGNews to a colleague To print, use this version